Source: Business Wire

Press Release: EpiBiologics : EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million

SAN MATEO, Calif.--(BUSINESS WIRE)--EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million

Read full article »

EpiBiologics's Competitors | EpiBiologics's News | EpiBiologics's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Ann Lee-Karlon

CEO Approval Rating

90/100

EpiBiologics is a California-based biotechnology company that researches and develops antibody-based protein degradation solutions for membrane and extracellular drug targets.